MediWound Shares Slide This Week; BARDA Moves in Focus
MediWound Ltd. shares fell 1.6% Friday to $14.33, down 13.6% since May 22, after first-quarter revenue dropped to $1.5 million from $4.0 million a year earlier. Net loss widened to $3.0 million. The company maintained its 2026 revenue forecast, expecting most sales later in the year. CEO Ofer Gonen cited slow enrollment in the EscharEx VALUE trial and anticipated second-half revenue from government contracts.